600763:SSETopchoice Medical Corp. Class A Analysis
Data as of 2026-05-29 - not real-time
CN¥37.41
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its short‑term, mid‑term and long‑term moving averages, and the MACD shows a bearish crossover with a negative histogram. RSI sits in the lower‑mid range, hinting at modest oversold pressure, while recent volatility has been elevated. Valuation pressure: The market price is well above the discounted cash‑flow estimate and the price‑to‑earnings multiple exceeds the industry average, indicating the stock is currently overvalued.
Fundamental backdrop: The company generates solid margins and a healthy return on equity, supports a sustainable dividend with a comfortable payout ratio, and carries a moderate debt load relative to cash. Low beta suggests limited market‑wide price swings, but geographic concentration in China adds a layer of macro risk. Overall, the picture is one of strong fundamentals weighed down by a pricey market valuation and bearish technical signals.
Fundamental backdrop: The company generates solid margins and a healthy return on equity, supports a sustainable dividend with a comfortable payout ratio, and carries a moderate debt load relative to cash. Low beta suggests limited market‑wide price swings, but geographic concentration in China adds a layer of macro risk. Overall, the picture is one of strong fundamentals weighed down by a pricey market valuation and bearish technical signals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below all moving averages
- bearish MACD momentum
- high recent volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- overvaluation relative to fundamentals
- steady cash flow and dividend sustainability
- moderate debt profile
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- stable demand for dental services
- low market beta indicating defensive characteristics
- consistent dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth1.40%
Profit Margin17.27%
P/E Ratio33.4
ROE12.67%
ROA6.94%
Debt/Equity23.96
P/B Ratio3.8
Op. Cash FlowCN¥824.1M
Free Cash FlowCN¥365.9M
Industry P/E27.8
Technical Analysis
TrendBearish
RSI38.1
SupportCN¥35.80
ResistanceCN¥43.45
MA 20CN¥39.29
MA 50CN¥40.90
MA 200CN¥43.73
MACDBearish
VolumeStable
Fear & Greed Index93.11
Valuation
Fair ValueCN¥10.67
GradeOvervalued
TypeBlend
Dividend Yield1.24%
Risk Assessment
Beta0.02
Volatility27.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.